Shu Dong

2.1k total citations
60 papers, 1.2k citations indexed

About

Shu Dong is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Shu Dong has authored 60 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 18 papers in Molecular Biology and 18 papers in Epidemiology. Recurrent topics in Shu Dong's work include Liver Disease Diagnosis and Treatment (11 papers), Pancreatic and Hepatic Oncology Research (9 papers) and Liver physiology and pathology (6 papers). Shu Dong is often cited by papers focused on Liver Disease Diagnosis and Treatment (11 papers), Pancreatic and Hepatic Oncology Research (9 papers) and Liver physiology and pathology (6 papers). Shu Dong collaborates with scholars based in China, United States and Hong Kong. Shu Dong's co-authors include David F. Clayton, Shi-Bing Su, Ping Liu, Hongyan Cao, Yanqin Bian, Mingyu Sun, Qiwen Chen, Fei Huang, Hao Zhang and Yanan Song and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Shu Dong

53 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shu Dong China 19 505 251 208 184 153 60 1.2k
Jong‐Gil Park South Korea 19 649 1.3× 332 1.3× 126 0.6× 84 0.5× 32 0.2× 61 1.5k
Diane S. Keeney United States 25 706 1.4× 41 0.2× 100 0.5× 143 0.8× 10 0.1× 52 1.9k
Jinyoung Park South Korea 16 271 0.5× 53 0.2× 44 0.2× 43 0.2× 35 0.2× 45 727
Celia Pilar Martinez‐Jimenez Germany 15 1.1k 2.1× 132 0.5× 167 0.8× 177 1.0× 9 0.1× 27 1.6k
Daniel Motola United States 14 521 1.0× 277 1.1× 131 0.6× 148 0.8× 16 0.1× 18 1.8k
Mamoru Nomura Japan 18 578 1.1× 61 0.2× 53 0.3× 369 2.0× 17 0.1× 52 1.2k
J. Alan Maschek United States 22 772 1.5× 260 1.0× 162 0.8× 71 0.4× 29 0.2× 51 1.6k
Kimihiko Oishi United States 15 463 0.9× 108 0.4× 53 0.3× 138 0.8× 19 0.1× 34 1.1k
Wen Zheng China 22 836 1.7× 107 0.4× 86 0.4× 92 0.5× 13 0.1× 59 1.6k
Walid G. Yasmineh United States 22 956 1.9× 98 0.4× 74 0.4× 125 0.7× 26 0.2× 52 1.8k

Countries citing papers authored by Shu Dong

Since Specialization
Citations

This map shows the geographic impact of Shu Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu Dong more than expected).

Fields of papers citing papers by Shu Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu Dong. The network helps show where Shu Dong may publish in the future.

Co-authorship network of co-authors of Shu Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Shu Dong. A scholar is included among the top collaborators of Shu Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu Dong. Shu Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ji, Dongmei, Yanjing Guo, Xin Liu, et al.. (2024). A phase II umbrella clinical trial of advanced salivary gland cancer based on molecular typing.. Journal of Clinical Oncology. 42(16_suppl). e18062–e18062. 2 indexed citations
5.
Yu, Bin, et al.. (2023). Associations of screen use with physical activity and social capital amid the COVID-19 pandemic: A network analysis of youths in China. Preventive Medicine. 177. 107780–107780. 1 indexed citations
6.
Yu, Wanqi, Xiaoqing Li, Shu Dong, et al.. (2022). Rural-urban disparities in the associations of residential greenness with diabetes and prediabetes among adults in southeastern China. The Science of The Total Environment. 860. 160492–160492. 18 indexed citations
7.
Cheng, Chien‐shan, et al.. (2022). Integrating network pharmacology and experimental models to investigate the efficacy of QYHJ on pancreatic cancer. Journal of Ethnopharmacology. 297. 115516–115516. 18 indexed citations
8.
Li, Xiaoqing, Bin Yu, Shu Dong, et al.. (2022). Associations and pathways between residential greenness and metabolic syndromes in Fujian Province. Frontiers in Public Health. 10. 1014380–1014380. 8 indexed citations
10.
Dong, Shu, Lei Wang, Hao Ying, et al.. (2017). Risk factors of liver metastasis from advanced pancreatic adenocarcinoma: a large multicenter cohort study. World Journal of Surgical Oncology. 15(1). 120–120. 16 indexed citations
11.
Dong, Shu, Hongyan Cao, Chao Wu, et al.. (2017). Urinary metabolomics analysis identifies key biomarkers of different stages of nonalcoholic fatty liver disease. World Journal of Gastroenterology. 23(15). 2771–2771. 56 indexed citations
12.
Li, Jianyuan, Hongyan Cao, Chao‐Liang Wu, et al.. (2017). Therapeutic mechanism of Yīn-Chén-Hāo decoction in hepatic diseases. World Journal of Gastroenterology. 23(7). 1125–1125. 50 indexed citations
14.
Song, Yanan, Shu Dong, Bin Wei, et al.. (2017). Metabolomic mechanisms of gypenoside against liver fibrosis in rats: An integrative analysis of proteomics and metabolomics data. PLoS ONE. 12(3). e0173598–e0173598. 41 indexed citations
15.
Lu, Yi-Yu, Yu Zhao, Yanan Song, et al.. (2015). Serum cytokine profiling analysis for zheng differentiation in chronic hepatitis B. Chinese Medicine. 10(1). 24–24. 13 indexed citations
16.
Song, Yanan, Qilong Chen, Shu Dong, et al.. (2015). Actions of Huangqi decoction against rat liver fibrosis: a gene expression profiling analysis. Chinese Medicine. 10(1). 39–39. 27 indexed citations
17.
Qiu, Xuemei, Shu Dong, Fengchang Qiao, et al.. (2013). HBx-mediated miR-21 upregulation represses tumor-suppressor function of PDCD4 in hepatocellular carcinoma. Oncogene. 32(27). 3296–3305. 101 indexed citations
18.
London, Sarah E., Shu Dong, Kirstin Replogle, & David F. Clayton. (2009). Developmental shifts in gene expression in the auditory forebrain during the sensitive period for song learning. Developmental Neurobiology. 69(7). 437–450. 40 indexed citations
19.
Dong, Shu & David F. Clayton. (2008). Partial dissociation of molecular and behavioral measures of song habituation in adult zebra finches. Genes Brain & Behavior. 7(7). 802–809. 30 indexed citations
20.
Dong, Shu & David F. Clayton. (2008). Habituation in songbirds. Neurobiology of Learning and Memory. 92(2). 183–188. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026